Inventor
KJAERGAARD KRISTIAN
DK23 patents
⚠️ This page may combine multiple inventors who share the name “KJAERGAARD KRISTIAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NOVO NORDISK AS
9 patentsUS8846045B2Sep 30, 2014
Anti-C5a receptor antibodies
NOVO NORDISK AS11 citations90
US10179814B2Jan 15, 2019
Site directed mutagenesis of TREM-1 antibodies for decreasing viscosity
NOVO NORDISK AS4 citations82
US10882916B2Jan 5, 2021
Anti-C5a receptor antibodies
NOVO NORDISK AS6 citations80
US10323097B2Jun 18, 2019
Anti-C5a receptor antibodies
NOVO NORDISK AS8 citations80
US9708403B2Jul 18, 2017
KIR-binding agents and methods of use thereof
NOVO NORDISK AS3 citations71
US12116408B2Oct 15, 2024
Site directed mutagenesis of TREM-1 antibodies for decreasing viscosity
NOVO NORDISK AS0 citations61
US11072654B2Jul 27, 2021
Site directed mutagenesis of TREM-1 antibodies for decreasing viscosity
NOVO NORDISK AS0 citations61
US9713644B2Jul 25, 2017
Antagonistic DR3 ligands
NOVO NORDISK AS0 citations47
US8765130B2Jul 1, 2014
Antagonistic DR3 ligands
NOVO NORDISK AS0 citations47
H LUNDBECK AS
5 patentsUS11111290B2Sep 7, 2021
Antibodies specific for hyperphosphorylated tau and methods of use thereof
H LUNDBECK AS6 citations83
US10647762B2May 12, 2020
Antibodies specific for hyperphosphorylated tau and methods of use thereof
H LUNDBECK AS5 citations82
US10487142B2Nov 26, 2019
Antibodies specific for hyperphosphorylated tau and methods of use thereof
H LUNDBECK AS5 citations82
US10472415B2Nov 12, 2019
Antibodies specific for hyperphosphorylated tau and methods of use
H LUNDBECK AS5 citations82
US12129289B2Oct 29, 2024
Antibodies specific for hyperphosphorylated tau and methods of use thereof
H LUNDBECK AS0 citations61